CSB Research Spotlight: Georgiev Lab—Developing antibody therapeutics against existing and emerging viral threats

Posted by daviskd2 on Tuesday, January 27, 2026 in News.

The Georgiev lab recently led a multi-institutional study, published in the journal Cell, that focused on the development of antibody therapeutics against existing and emerging viral threats, including RSV (respiratory syncytial virus) and avian influenza viruses.

The study showed that a protein language model could design functional human antibodies that recognized the unique antigen sequencies (surface proteins) of

specific viruses, without requiring part of the antibody sequence as a starting template.

Read more about using AI to speed antibody design to thwart novel viruses.